New Insights on Obesity Treatment
For roughly five decades, many countries in the West have been grappling with a significant obesity crisis. The surge in ultra-processed foods, coupled with increasingly sedentary lifestyles—like long hours spent in offices or stuck in traffic—has led to a concerning situation. About 40% of adults in the United States now face obesity challenges.
While diet and exercise are still crucial for managing weight, recent advancements in science offer new avenues to address this epidemic. One prominent player is glucagon-like peptide-1, or GLP-1, a synthetic hormone that signals feelings of fullness to the brain. This discovery, inspired by a peptide hormone from the venom of the Gila monster, serves as the basis for medications like Wegovy and Ozempic. However, researchers are exploring other potential methods to combat obesity.
In a recent study featured in The European Molecular Biology Organization (EMBO) Journal, scientists from the Weizmann Institute of Science in Israel investigated the effects of a protein known as MTCH2, or “Mitch.” Traditionally, Mitch is involved in programmed cell death, metabolism, and mitochondrial dynamics. Over the past decade, the study’s senior author, Atan Gross, has focused on how diminishing the expression of this protein can enhance fat and carbohydrate combustion while preventing the formation of new fat cells.
Gross remarked, “We discovered that deleting Mitch led to a major drop in fats in membranes. Simultaneously, we observed an uptick in fatty substances used for energy production, indicating that fat was being broken down from the membrane and utilized as fuel. Essentially, we demonstrated that Mitch governs the fate of fat in human cells.”
In a previous study in 2016, Gross and colleagues revealed that suppressing MTCH2 in mice highlighted Mitch as a crucial regulator of muscle metabolism and energy balance, suggesting that further research on this protein could be beneficial in tackling various metabolic diseases, including diabetes and obesity. In this new research, the team, led by Sabita Chourasia, assessed human cells experiencing Mitch suppression, finding that, similar to the mice, energy production dipped, thereby boosting the body’s reliance on fat stores.
Chourasia explained, “We saw an increase in cellular respiration, which is how cells generate energy from nutrients like carbohydrates and fats using oxygen. This may clarify the increased muscular endurance observed in our prior mouse experiments.”
The researchers also delved into Mitch’s role in fat storage. Knowing that women with obesity show elevated levels of this protein, they speculated that Mitch involves cell differentiation. They discovered that Mitch aids progenitor cells in accumulating fat and maturing into fully developed fat cells. When Mitch was suppressed, the formation of mature fat cells lessened. Gross noted that fat accumulation demands significant energy, which is scarce in cells without Mitch.
Historically, the MTCH2 protein helped early humans survive by acting as an energy reserve during tough times. However, given the current environment of plentiful food, this mechanism seems maladaptive. If future therapies can realign Mitch with today’s biological context, we might finally see an end to the obesity crisis.
You Might Also Like
